A single centre experience with CytoSorb® as an adjunct therapy in critically ill patients with sepsis: a case series IJMDAT 2023; 6: e398 DOI: 10.32113/ijmdat_20236_398
CytoSorb® therapy: a new approach to treat critically ill patients with COVID-19 – a retrospective study IJMDAT 2023; 6: e401 DOI: 10.32113/ijmdat_20236_401